Early Treatment of Atrial Fibrillation for Stroke Prevention Trial
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 2789 participants.
Also called NCT01288352
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose prevention
- Phase
- Phase 4
- Enrolled
- 2,789 participants
- Sponsor
- Registry
-
NCT01288352 -
2010-021258-20
-
- Other papers using this trial's data
- Association of genetic risk and outcomes in patients with atrial fibrillation: interactions with early rhythm control in the EAST-AFNET4 trial
- Diabetes and Obesity and Treatment Effect of Early Rhythm Control vs Usual Care in Patients With Atrial Fibrillation: A Secondary Analysis of the EAST-AFNET 4 Randomized Clinical Trial
- Early Rhythm Control in Patients With Atrial Fibrillation and High Comorbidity Burden
- Early rhythm control in patients with atrial fibrillation and cancer: a subgroup analysis of the EAST-AFNET 4 trial
- Early rhythm-control therapy for atrial fibrillation in patients with a history of stroke: a subgroup analysis of the EAST-AFNET 4 trial
- Effectiveness and Safety of Early Rhythm Control in Patients With Atrial Fibrillation and Chronic Kidney Disease
- Interactions of blood biomolecules with early rhythm control in atrial fibrillation patients: exploratory analysis of the EAST-AFNET 4 biomolecule study
- Safety and efficacy of long-term sodium channel blocker therapy for early rhythm control: the EAST-AFNET 4 trial
- Systematic, early rhythm control strategy for atrial fibrillation in patients with or without symptoms: the EAST-AFNET 4 trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Belgium, Czechia, Denmark, France, Germany, Italy, Netherlands, Poland, Spain, Switzerland, United Kingdom
- Registry status
- Completed
Technical summary
Registry record NCT01288352. Randomized; no masking; primary purpose prevention. Start 2011-07-01 (actual); primary completion 2020-03-06 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Early Treatment of Atrial Fibrillation for Stroke Prevention Trial
- Acronym
- EAST
- Condition
- Atrial Fibrillation
- Condition
- Stroke
- Intervention (Other)
- early standardised rhythm control
- Lead sponsor
- Atrial Fibrillation Network
- Collaborator
- Sanofi
- Collaborator
- Abbott
- Collaborator
- The German Heart Foundation
- Collaborator
- European Heart Rhythm Association (EHRA)
- Collaborator
- BMBF (German Ministry for Science)
- Collaborator
- Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK)
Record details
- Record id
cardio:ct-nct01288352- Content hash
5cdac0d541a1e5ad4fd1be27ea3ea49d76d4aa51c98a4e9393f4234e066a63f5